S-1 Filing

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

October 6, 2022

Accession Number

0001437749-22-023768

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →